APL-like subset within <i>NPM1</i>-mutated AML: A distinct immunophenotype correlating with early vascular complications. [PDF]
Mannelli F +32 more
europepmc +1 more source
Frontline ATRA-ATO Therapy for Acute Promyelocytic Leukemia in Japan: Results From the Prospective Multicenter FBMTG-APL2017 Trial. [PDF]
Takase K +14 more
europepmc +1 more source
The autophagy switch: A critical determinant of arsenic-induced carcinogenesis and cancer therapy. [PDF]
Zeinvand-Lorestani M +2 more
europepmc +1 more source
Acute Promyelocytic Leukemia Presenting as Spontaneous Abortion Amidst Tropical Fever Season: A Diagnostic Challenge. [PDF]
Rathod A, Gupta M, Palta A.
europepmc +1 more source
Severe Gout During Arsenic Therapy: Insights on Oxidative Stress and Interleukin-1β in Gout. [PDF]
Hamilton J, Alexander A.
europepmc +1 more source
International testing and refinement of AI algorithms predicting acute leukemia subtypes from routine laboratory data. [PDF]
Turki AT +43 more
europepmc +1 more source
Acute Promyelocytic Leukemia with double minute chromosomes: a rare case with high relapse risk. [PDF]
Sasaki Y +11 more
europepmc +1 more source
Plasma levels of Human Granulocytic Elastase-alpha-Proteinase Inhibitor Complex (E-alpha1PI) in Leukemia [PDF]
Hiller, E., Jochum, Marianne
core
The novel ETV6::RARA fusion gene, identified in acute promyelocytic leukemia, is sensitive to invitro all-tans retinoic acid and arsenic trioxide administrations. [PDF]
Hassani MA +8 more
europepmc +1 more source
Asciminib and pulsed ATRA as post-remission therapy in T315I mutated PML-RARA-positive blast crisis of chronic myeloid leukemia. [PDF]
Mazzarella R +17 more
europepmc +1 more source

